Between October 13th and 15th, 21 of Bluepharma’s employees and partners were in Madrid to represent the group at the CPhI Worldwide 2015. The event was remarkable by the success and hospitality that have been the trademarks of Bluepharma every year.
With a total of 319 meetings, Bluepharma established new contacts and strengthened partnerships. The greatest demand was from European countries, followed by the MENA region, and there are also products to highlight: moxifloxacin, abiraterone, febuxostat and valganciclovir (Business Development Department report).
With a stronger international presence, the internationalization strategy of Bluepharma is becoming well-established. For the CEO, Paulo Barradas Rebelo, "it is evident and very rewarding the recognition of Bluepharma in the world. Which is why, this year, we have once again won the European Business Award in the export category in Portugal”.
